Growth N. V. Biotech, 10% Owner at Black Diamond Therapeutics, Inc. (BDTX), bought 355,112 shares at $3.57 ($1.2M) on 2022-04-13, disclosed to the SEC on 2022-04-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.42 | 150,000 | $513K | 41.2% |
| 2 | $3.57 | 102,556 | $366K | 29.4% |
| 3 | $3.57 | 102,556 | $366K | 29.4% |
| Total | $3.51 avg | 355,112 | $1.2M | 100% |
| Filing → |
| BDTX | BUY | 2023-06-29 | $9.6M | — | Filing → |
| BDTX | BUY | 2022-11-02 | $449K | — | Filing → |
| EPIX | BUY | 2022-10-28 | $8.2M | — | Filing → |